BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharming announces sale of priority review voucher

  Pharming Group N.V. announces that it has entered into a definitive agreement with Novartis Pharma A.G. to sell its Rare Pediatric Disease Priority Review Voucher to Novartis for a pre-agreed, one-time payment of approximately US$21.1 million shortly after closing.

  June 1, 2023

   · 

  5 min read
• IRLAB to present at Redeye Growth Day 2023 in Stockholm on June 1, 2023

  IRLAB Therapeutics AB announced that the company will participate at Redeye Growth Day 2023 on Thursday, June 1, 2023, in Stockholm, Sweden.

  June 1, 2023

   · 

  1 min read
• Job Trends

  Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan

  Sanofi launches Action 2023, its global employee shareholder plan, open to around 86,000 employees in 56 countries.

  June 1, 2023

   · 

  5 min read
• Genetown

  Oxurion to Participate in Upcoming June 2023 Conferences

  Oxurion NV, a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced that the company will participate in three conferences in June:

  June 1, 2023

   · 

  1 min read
• Biotech Beach

  CLS Americas Announces the National Institutes of Health Clinical Center Placed its 1st Order of the TRANBERG™ Thermal Therapy System for its Research Study - MRI/Ultrasound Fusion-Guided FLA of Prostate Tissue and Prostate Cancer

  Clinical Laserthermia Systems Americas, Inc., a leading provider of office-based, focal laser ablation systems for urologists, announced it has received the first order of its TRANBERG™ Thermal Therapy System and accessories from the National Institutes of Health Clinical Center.

  June 1, 2023

   · 

  3 min read
• Drug Development

  Inotrem Announces Publication of Two Key Articles on Nangibotide Phase II Programs in Peer-reviewed Medical Journals

  Inotrem announced the publication of the results of two phase 2 clinical studies in the The Lancet Respiratory Medicine and in eClinicalMedicine.

  June 1, 2023

   · 

  6 min read
• Philogen Announces Clinical Trial Collaboration with MSD

  Philogen S.p.A. announces that it has entered into a Clinical Trial Collaboration and Supply Agreement with MSD.

  June 1, 2023

   · 

  3 min read
• Drug Development

  Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infections

  Pneumagen announced that it has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil in Chronic Obstructive Pulmonary Disease patients suffering from virus induced exacerbations.

  June 1, 2023

   · 

  3 min read
• invoX Pharma Increases Investment in pHion Therapeutics to Further Develop Next Generation of mRNA Vaccines

  invoX Pharma Limited announced that it has completed a second tranche of investment in pHion Therapeutics, a next-generation mRNA vaccine company.

  June 1, 2023

   · 

  4 min read
• Gradient Denervation Technologies Enrolls Initial Patient in First-In-Human Study of Pulmonary Artery Denervation Technology

  Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive device for treating certain heart failure patients with associated pulmonary hypertension, announced the successful first patient enrollment in its first-in-human clinical study.

  June 1, 2023

   · 

  2 min read